Wilmington, 19803, DE,
United States
Prelude Therapeutics Incorporated Technographics
Prelude Therapeutics Incorporated Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Prelude Therapeutics Incorporated and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 116 Prelude Therapeutics Incorporated employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Prelude Therapeutics Incorporated has purchased the following applications: Microsoft 365 for Collaboration in 2016, New Relic APM for Application Performance Management in 2021, Certara GlobalSubmit for Governance, Risk and Compliance in 2019 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Prelude Therapeutics Incorporated is running and its propensity to invest more and deepen its relationship with Microsoft , New Relic , Certara or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Prelude Therapeutics Incorporated revenues, which have grown to $13.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Prelude Therapeutics Incorporated intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Prelude Therapeutics Incorporated Tech Stack and Enterprise Applications
Prelude Therapeutics Incorporated Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2016 | 2016 |
In 2016, Prelude Therapeutics Incorporated provisioned Microsoft 365 as its cloud-based Collaboration platform. The Microsoft 365 deployment is surfaced on the company website and reflects a tenant level SaaS adoption for core productivity services, including Exchange Online email, SharePoint document management, Teams collaboration, and OneDrive storage. Prelude Therapeutics Incorporated Microsoft 365 Collaboration supports corporate communications and research support functions alongside general administrative productivity.
Configuration and operational controls follow standard SaaS patterns with centralized user provisioning, cloud storage for document lifecycle, collaborative workspaces, and Microsoft identity services for authentication. The implementation scope targets corporate business functions such as research support, administrative operations, and corporate communications, with governance centered on tenant administration, access control, and content lifecycle workflows consistent with Collaboration category deployments.
|
Prelude Therapeutics Incorporated ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| New Relic | Legacy | New Relic APM | Application Performance Management | ITSM | n/a | 2021 | 2021 |
In 2021, Prelude Therapeutics Incorporated implemented New Relic APM to instrument and monitor its public website. The deployment targets application-level observability and aligns with Application Performance Management practices for their web presence.
New Relic APM was configured with agent-based instrumentation in the web application stack, capturing transaction traces, error analytics, and response time metrics. The New Relic APM setup emphasizes centralized dashboards and alerting, enabling continuous visibility into application performance and exception patterns.
Operational coverage is focused on web operations and engineering teams that support the corporate website, with telemetry used to prioritize incident triage and code-level investigations. Prelude Therapeutics Incorporated uses New Relic APM as the core Application Performance Management tool to surface application telemetry for those business functions.
Governance workstreams established standardized monitoring dashboards and alert thresholds, with phased rollout of instrumentation across the site. Configuration and dashboard ownership reside with internal engineering and operations staff, reflecting an embedded monitoring practice for the company website.
|
Prelude Therapeutics Incorporated TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Certara | Legacy | Certara GlobalSubmit | Governance, Risk and Compliance | TRM | n/a | 2019 | 2019 |
In 2019, Prelude Therapeutics Incorporated implemented Certara GlobalSubmit in Governance, Risk and Compliance to publish, validate, and review eCTD regulatory submissions. The Certara GlobalSubmit implementation was targeted at regulatory submission publishing and quality control for United States filings, aligning the application to regulatory operations and eCTD authoring workflows.
Configuration centered on Certara GlobalSubmit PUBLISH, VALIDATE and WebReview, enabling automated validation checks, packaged eCTD sequence creation and web based collaborative review. The deployment emphasized publishing automation and QC gating, consistent with Governance, Risk and Compliance functionality for submission readiness and conformance verification.
Operational scope covered United States regulatory submissions and a small centralized regulatory team within Prelude, shifting QC work from manual document review to system led validation and web review. Business functions impacted included regulatory operations, document control and quality assurance, with GlobalSubmit used as the authoritative publishing and QC tool for submission packages.
Governance and workflow changes included centralized publishing workflows, staged validation gates using VALIDATE, and collaborative WebReview sign off to shorten review cycles. The implementation cut QC from hours to minutes and improved compliance for submission packages.
|
Prelude Therapeutics Incorporated IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2016 | 2016 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2018 | 2018 |
|
IT Decision Makers and Key Stakeholders at Prelude Therapeutics Incorporated
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Prelude Therapeutics Incorporated Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||